Leerink Partnrs Estimates Humana's Q1 Earnings (NYSE:HUM)

Humana Inc. (NYSE:HUM - Free Report) - Leerink Partnrs raised their Q1 2025 earnings per share estimates for Humana in a research note issued on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now expects that the insurance provider will post earnings per share of $9.89 for the quarter, up from their prior estimate of $6.91. The consensus estimate for Humana's current full-year earnings is $16.11 per share. Leerink Partnrs also issued estimates for Humana's Q2 2025 earnings at $5.53 EPS, Q3 2025 earnings at $1.60 EPS, Q4 2025 earnings at ($0.52) EPS, Q1 2026 earnings at $10.27 EPS and Q3 2026 earnings at $1.10 EPS.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%.

A number of other equities analysts also recently commented on the company. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Bank of America upgraded Humana from an "underperform" rating to a "neutral" rating and lifted their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research note on Monday, January 6th. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Finally, Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $285.68.

Humana Stock Up 1.3 %

NYSE:HUM traded up $3.41 during mid-day trading on Friday, reaching $257.24. The stock had a trading volume of 1,418,958 shares, compared to its average volume of 1,706,863. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The stock's 50 day simple moving average is $270.62 and its two-hundred day simple moving average is $292.21. Humana has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a market capitalization of $30.97 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Pinnacle Wealth Management Advisory Group LLC increased its holdings in shares of Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock valued at $272,000 after buying an additional 37 shares in the last quarter. Atlas Brown Inc. increased its holdings in shares of Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after buying an additional 38 shares in the last quarter. Moors & Cabot Inc. increased its holdings in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock valued at $519,000 after buying an additional 40 shares in the last quarter. Mather Group LLC. increased its holdings in shares of Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after buying an additional 41 shares in the last quarter. Finally, Capital Advisors Ltd. LLC increased its holdings in shares of Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock valued at $53,000 after buying an additional 43 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.32% of the stock is owned by corporate insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.